{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT01962415",
            "orgStudyIdInfo": {
                "id": "PRO13100018"
            },
            "organization": {
                "fullName": "University of Pittsburgh",
                "class": "OTHER"
            },
            "briefTitle": "Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT",
            "officialTitle": "A Phase II Study of Reduced Intensity Conditioning in Pediatric Patients and Young Adults \u226455 Years of Age With Non-Malignant Disorders Undergoing Umbilical Cord Blood, Bone Marrow, or Peripheral Blood Stem Cell Transplantation",
            "acronym": "HSCT+RIC",
            "therapeuticArea": [
                "Endocrinology",
                "Immunology and Rheumatology",
                "Other",
                "Orthopedics"
            ],
            "study": "reduced-intensity-conditioning-for-non-malignant-disorders-undergoing-ucbt-bmt-or-pbsct"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-03",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2014-02-04",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2024-11",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2013-10-10",
            "studyFirstSubmitQcDate": "2013-10-10",
            "studyFirstPostDateStruct": {
                "date": "2013-10-14",
                "type": "ESTIMATED"
            },
            "lastUpdateSubmitDate": "2024-03-30",
            "lastUpdatePostDateStruct": {
                "date": "2024-04-02",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR_INVESTIGATOR",
                "investigatorFullName": "Paul Szabolcs",
                "investigatorTitle": "Chief, BMT-CT at CHP of UPMC and Professor of Pediatrics and Immunology, University of Pittsburgh",
                "investigatorAffiliation": "University of Pittsburgh"
            },
            "leadSponsor": {
                "name": "Paul Szabolcs",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). After transplant, subjects will be followed for late effects and for ongoing graft success.",
            "detailedDescription": "For some non-malignant diseases (NMD; i.e., thalassemia, sickle cell disease, most immune deficiencies) a hematopoietic stem cell transplant may be curative by healthy donor stem cell engraftment alone. HSCT in patients with NMD differs from that in malignant disorders for two important reasons: 1) these patients are typically na\u00efve to chemotherapy and immunosuppression. This may potentially lead to difficulties with engraftment. And 2) RIC with subsequent bone marrow chimerism may be beneficial even in mixed chimerism and result in decreased transplant-related mortality (TRM). Nevertheless, any previous organ damage, as a result of the underlying disease, may remain present after the HSCT.\n\nFor other diseases (metabolic disorders, some immunodeficiencies, etc.), a transplant is not curative. For these diseases, the main intent of the transplant is to slow down, or stop, the progress of the disease. In select few cases/diseases, the presence of healthy bone marrow derived cells may even prevent progression and prevent neurological decline.\n\nIn this research study, instead of using the standard myeloablative conditioning, the study doctor is using RIC, in which significantly lower doses of chemotherapy will be used. The lower doses may not eradicate every stem cell in the patient's bone marrow, however, in the presented combination, the intention is to eliminate already formed immune cells and provide maximum growth advantage to healthy donor stem cells. This paves the way to successful engraftment of donor stem cells. Engrafting donor stem cells can outcompete, and donor lymphocytes could suppress, the patients' surviving stem cells. With RIC, the side effects on the brain, heart, lung, liver, and other organ functions are less severe and late toxic effects should also be reduced.\n\nThe purpose of this study is to collect data from the patients undergoing reduced-intensity conditioning before HSCT, and compare it to the standard myeloablative conditioning. It is expected there will be therapeutic benefits, paired with better survival rate, less organ toxicity and improved quality of life, following the RIC compared to the myeloablative regimen."
        },
        "conditionsModule": {
            "conditions": [
                "Primary Immunodeficiency (PID)",
                "Congenital Bone Marrow Failure Syndromes",
                "Inherited Metabolic Disorders (IMD)",
                "Hereditary Anemias",
                "Inflammatory Conditions",
                "Systemic Juvenile Idiopathic Arthritis (sJIA)"
            ],
            "keywords": [
                "Severe Combined Immune Deficiency (SCID)",
                "Omenn Syndrome",
                "Bare Lymphocyte Syndrome (BLS)",
                "Combined Immune Deficiency (CID) syndromes",
                "Combined Variable Immune Deficiency (CVID) syndrome",
                "Wiskott-Aldrich Syndrome",
                "Leukocyte adhesion deficiency",
                "Chronic granulomatous disease (CGD)",
                "X-linked Hyper IgM (XHIM) syndrome",
                "IPEX syndrome",
                "Chediak - Higashi Syndrome",
                "Autoimmune Lymphoproliferative Syndrome (ALPS)",
                "Hemophagocytic Lymphohistiocytosis (HLH) syndromes",
                "Lymphocyte Signaling defects",
                "Dyskeratosis Congenita (DC)",
                "Congenital Amegakaryocytic Thrombocytopenia (CAMT)",
                "Osteopetrosis",
                "Mucopolysaccharidoses",
                "Hurler syndrome (MPS I)",
                "Hunter syndrome (MPS II)",
                "Leukodystrophies",
                "Krabbe Disease",
                "Metachromatic leukodystrophy (MLD)",
                "X-linked adrenoleukodystrophy (ALD)",
                "Alpha mannosidosis",
                "Gaucher Disease",
                "Thalassemia major",
                "Sickle cell disease (SCD)",
                "Diamond Blackfan Anemia (DBA)",
                "Crohn's Disease",
                "Inflammatory Bowel Disease",
                "Hematopoietic Stem Cell Transplant (HSCT)",
                "Congenital transfusion dependent anemias",
                "Globoid cell leukodystrophy",
                "Hereditary diffuse leukoencephalopathy with spheroids (HDLS)",
                "Systemic Juvenile Idiopathic Arthritis (sJIA)"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "NON_RANDOMIZED",
                "interventionModel": "PARALLEL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "NONE"
                }
            },
            "enrollmentInfo": {
                "count": 100,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "UCBT:transfusion dependent anemias or increased rejection risk",
                    "type": "EXPERIMENTAL",
                    "description": "Day -21 to -19: Alemtuzumab + Hydroxyurea; Day -18 to -10: Hydroxyurea; Day -9 to -5: Fludarabine + Hydroxyurea; Day -4 to -3: Melphalan; Day -2: Thiotepa; Day -1: Rest; Day 0: Transplant",
                    "interventionNames": [
                        "Drug: Hydroxyurea",
                        "Drug: Alemtuzumab",
                        "Drug: Fludarabine",
                        "Drug: Melphalan",
                        "Drug: Thiotepa"
                    ]
                },
                {
                    "label": "BMT, PBSCT and not transfusion dependent UCBT",
                    "type": "EXPERIMENTAL",
                    "description": "Start of conditioning to Day -15: Hydroxyurea; Day -14 to -13: Alemtuzumab + Hydroxyurea; Day -12 to -10: Hydroxyurea; Day -9 to -5: Fludarabine + Hydroxyurea; Day -4 to -3: Melphalan; Day -2: Thiotepa; Day -1: Rest; Day 0: Transplant",
                    "interventionNames": [
                        "Drug: Hydroxyurea",
                        "Drug: Alemtuzumab",
                        "Drug: Fludarabine",
                        "Drug: Melphalan",
                        "Drug: Thiotepa"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Hydroxyurea",
                    "description": "Oral administration at 30 mg/kg/day.",
                    "armGroupLabels": [
                        "BMT, PBSCT and not transfusion dependent UCBT",
                        "UCBT:transfusion dependent anemias or increased rejection risk"
                    ],
                    "otherNames": [
                        "hydroxycarbamide",
                        "Hydrea",
                        "Droxia"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Alemtuzumab",
                    "description": "Intravenous (IV) administration. The first dose for each arm will be a test dose (0.2 mg/kg max 5 mg). The treatment doses of alemtuzumab will be based on the patients' assigned stratum as determined by their age, lymphocyte count and presence of infection.\n\nStratum 1: 1 mg/kg (max dose of 30 mg); Stratum 2: 0.5 mg/kg (max dose of 30 mg); Stratum 3: No treatment dose, test dose only.",
                    "armGroupLabels": [
                        "BMT, PBSCT and not transfusion dependent UCBT",
                        "UCBT:transfusion dependent anemias or increased rejection risk"
                    ],
                    "otherNames": [
                        "Campath"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Fludarabine",
                    "description": "IV administration at 30 mg/m2/day or 1 mg/kg/dose, whichever is lower.",
                    "armGroupLabels": [
                        "BMT, PBSCT and not transfusion dependent UCBT",
                        "UCBT:transfusion dependent anemias or increased rejection risk"
                    ],
                    "otherNames": [
                        "Fludara"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Melphalan",
                    "description": "IV administration at 70 mg/m2/dose.",
                    "armGroupLabels": [
                        "BMT, PBSCT and not transfusion dependent UCBT",
                        "UCBT:transfusion dependent anemias or increased rejection risk"
                    ],
                    "otherNames": [
                        "Melphalan hydrochloride",
                        "Alkeran"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Thiotepa",
                    "description": "IV administration at 200 mg/m2/dose",
                    "armGroupLabels": [
                        "BMT, PBSCT and not transfusion dependent UCBT",
                        "UCBT:transfusion dependent anemias or increased rejection risk"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Post-transplant treatment-related mortality (TRM)",
                    "description": "The number of deaths related to the research intervention at day 100, 6 months, and 1 year post-transplant.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Neurodevelopmental milestones",
                    "description": "Evaluation of the pace of attaining neurodevelopmental milestones after reduced-intensity conditioning as compared to myeloablative conditioning historical controls from the target population(s).",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Immune Reconstitution",
                    "description": "Evaluation of the pace of immune reconstitution.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Severe opportunistic infections",
                    "description": "Evaluation of the incidence of severe opportunistic infections.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "GVHD occurrence",
                    "description": "Description of the incidence of acute graft versus host disease (GVHD) (II-IV) and chronic extensive GVHD.",
                    "timeFrame": "1 year post-transplant"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Donor cell engraftment",
                    "description": "Determination of the feasibility of attaining robust donor cell engraftment (\\>50% donor chimerism at 6 months) following reduced-intensity conditioning (RIC) regimens prior to HSCT in the target population(s).",
                    "timeFrame": "6 months post-transplant"
                },
                {
                    "measure": "Normal enzyme level",
                    "description": "Determination of the feasibility of attaining and sustaining normal enzyme levels in the target population(s).",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Neutrophil recovery",
                    "description": "Determination of the pace of neutrophil recovery.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Platelet recovery",
                    "description": "Determination of the pace of platelet recovery.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Grade 3-4 organ toxicity",
                    "description": "The number of grade 3-4 organ adverse events.",
                    "timeFrame": "1 year post-transplant"
                },
                {
                    "measure": "Late graft failure",
                    "description": "Evaluation of the incidence of late graft failure.",
                    "timeFrame": "1 year post-transplant"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion:\n\n1. A 4/6, 5/6 or 6/6 HLA matched related or unrelated UCB unit available that will deliver a pre-cryopreservation total nucleated cell dose of \u2265 3 x 10e7 cells/kg, or double unit grafts, each cord blood unit delivering at least 2 x 10e7 cells/kg OR an 8 of 8 or 7 of 8 HLA allele level matched unrelated donor bone marrow or peripheral blood progenitor graft.\n2. Adequate organ function as measured by:\n\n   1. Creatinine \u2264 2.0 mg/dL and creatinine clearance \u2265 50 mL/min/1.73 m2.\n   2. Hepatic transaminases (ALT/AST) \u2264 4 x upper limit of normal (ULN).\n   3. Adequate cardiac function by echocardiogram or radionuclide scan (shortening fraction \\> 26% or ejection fraction \\> 40% or \\> 80% of normal value for age).\n   4. Pulmonary evaluation testing demonstrating CVC or FEV1/FVC of \u2265 50% of predicted for age and/or resting pulse oximeter \u2265 92% on room air or clearance by the pediatric or adult pulmonologist. For adult patients DLCO (corrected for hemoglobin) should be \u2265 50% of predicted if the DLCO can be obtained.\n3. Written informed consent and/or assent according to FDA guidelines.\n4. Negative pregnancy test if pubertal and/or menstruating.\n5. HIV negative.\n6. A non-malignant disorder amenable to treatment by stem cell transplantation, including but not limited to:\n\n   1. Primary Immunodeficiency syndromes including but not limited to:\n\n      * Severe Combined Immune Deficiency (SCID) with NK cell activity\n      * Omenn Syndrome\n      * Bare Lymphocyte Syndrome (BLS)\n      * Combined Immune Deficiency (CID) syndromes\n      * Combined Variable Immune Deficiency (CVID) syndrome\n      * Wiskott-Aldrich Syndrome\n      * Leukocyte adhesion deficiency\n      * Chronic granulomatous disease (CGD)\n      * X-linked Hyper IgM (XHIM) syndrome\n      * IPEX syndrome\n      * Chediak - Higashi Syndrome\n      * Autoimmune Lymphoproliferative Syndrome (ALPS)\n      * Hemophagocytic Lymphohistiocytosis (HLH) syndromes\n      * Lymphocyte Signaling defects\n      * Other primary immune defects where hematopoietic stem cell transplantation may be beneficial\n   2. Congenital bone marrow failure syndromes including but not limited to:\n\n      * Dyskeratosis Congenita (DC)\n      * Congenital Amegakaryocytic Thrombocytopenia (CAMT)\n      * Osteopetrosis\n   3. Inherited Metabolic Disorders (IMD) including but not limited to:\n\n      * Mucopolysaccharidoses\n\n        * Hurler syndrome (MPS I)\n        * Hunter syndrome (MPS II)\n      * Leukodystrophies\n\n        * Krabbe Disease, also known as globoid cell leukodystrophy\n        * Metachromatic leukodystrophy (MLD)\n        * X-linked adrenoleukodystrophy (ALD)\n        * Hereditary diffuse leukoencephalopathy with spheroids (HDLS)\n      * Other inherited metabolic disorders\n\n        * alpha mannosidosis\n        * Gaucher Disease\n      * Other inheritable metabolic diseases where hematopoietic stem cell transplantation may be beneficial.\n   4. Hereditary anemias\n\n      * Thalassemia major\n      * Sickle cell disease (SCD) - patients with sickle disease must have one or more of the following:\n\n        * Overt or silent stroke\n        * Pain crises \u2265 2 episodes per year for past year\n        * One or more episodes of acute chest syndrome\n        * Osteonecrosis involving \u2265 1 joints\n        * Priapism\n      * Diamond Blackfan Anemia (DBA)\n      * Other congenital transfusion dependent anemias\n   5. Inflammatory Conditions\n\n      * Crohn's Disease/Inflammatory Bowel Disease\n\nExclusion:\n\n1. Allogeneic hematopoietic stem cell transplant within the previous 6 months.\n2. Any active malignancy or MDS.\n3. Severe acquired aplastic anemia.\n4. Uncontrolled bacterial, viral or fungal infection (currently taking medication and with progression of clinical symptoms).\n5. Pregnancy or nursing mother.\n6. Poorly controlled pulmonary hypertension.\n7. Any condition that precludes serial follow-up.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "2 Months",
            "maximumAge": "55 Years",
            "stdAges": [
                "CHILD",
                "ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Paul Szabolcs, MD",
                    "role": "CONTACT",
                    "phone": "412-692-5427",
                    "email": "paul.szabolcs@chp.edu"
                },
                {
                    "name": "Shawna McIntyre, RN",
                    "role": "CONTACT",
                    "phone": "412-692-5552",
                    "email": "mcintyresm@upmc.edu"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Paul Szabolcs, MD",
                    "affiliation": "University of Pittsburgh",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "UPMC Children's Hospital of Pittsburgh",
                    "status": "RECRUITING",
                    "city": "Pittsburgh",
                    "state": "Pennsylvania",
                    "zip": "15224",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Shawna McIntyre, RN",
                            "role": "CONTACT",
                            "phone": "412-692-5552",
                            "email": "mcintyresm@upmc.edu"
                        },
                        {
                            "name": "Maria Escolar, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Randy Windreich, MD",
                            "role": "SUB_INVESTIGATOR"
                        },
                        {
                            "name": "Craig Byersdorfer, MD",
                            "role": "SUB_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 40.44062,
                        "lon": -79.99589
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "32750127",
                    "type": "RESULT",
                    "citation": "Vander Lugt MT, Chen X, Escolar ML, et al. Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders. Blood Adv. 2020;4(13):3041-3052. Blood Adv. 2020 Aug 11;4(15):3508. doi: 10.1182/bloodadvances.2020002967. No abstract available."
                },
                {
                    "pmid": "32634238",
                    "type": "DERIVED",
                    "citation": "Vander Lugt MT, Chen X, Escolar ML, Carella BA, Barnum JL, Windreich RM, Hill MJ, Poe M, Marsh RA, Stanczak H, Stenger EO, Szabolcs P. Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders. Blood Adv. 2020 Jul 14;4(13):3041-3052. doi: 10.1182/bloodadvances.2020001940. Erratum In: Blood Adv. 2020 Aug 11;4(15):3508. doi: 10.1182/bloodadvances.2020002967."
                }
            ],
            "seeAlsoLinks": [
                {
                    "label": "Reduced-intensity single-unit unrelated cord blood transplant with optional immune boost for nonmalignant disorders",
                    "url": "https://pubmed.ncbi.nlm.nih.gov/32634238/"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "NO"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000001168",
                    "term": "Arthritis"
                },
                {
                    "id": "D000001171",
                    "term": "Arthritis, Juvenile"
                },
                {
                    "id": "D000000740",
                    "term": "Anemia"
                },
                {
                    "id": "D000080983",
                    "term": "Bone Marrow Failure Disorders"
                },
                {
                    "id": "D000010198",
                    "term": "Pancytopenia"
                },
                {
                    "id": "D000080984",
                    "term": "Congenital Bone Marrow Failure Syndromes"
                },
                {
                    "id": "D000081207",
                    "term": "Primary Immunodeficiency Diseases"
                },
                {
                    "id": "D000008659",
                    "term": "Metabolic Diseases"
                },
                {
                    "id": "D000013577",
                    "term": "Syndrome"
                }
            ],
            "ancestors": [
                {
                    "id": "D000004194",
                    "term": "Disease"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000007592",
                    "term": "Joint Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000007153",
                    "term": "Immunologic Deficiency Syndromes"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000012216",
                    "term": "Rheumatic Diseases"
                },
                {
                    "id": "D000003240",
                    "term": "Connective Tissue Diseases"
                },
                {
                    "id": "D000001327",
                    "term": "Autoimmune Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                },
                {
                    "id": "D000001855",
                    "term": "Bone Marrow Diseases"
                },
                {
                    "id": "D000095542",
                    "term": "Cytopenia"
                },
                {
                    "id": "D000007232",
                    "term": "Infant, Newborn, Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M16355",
                    "name": "Syndrome",
                    "asFound": "Syndrome",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4476",
                    "name": "Arthritis",
                    "asFound": "Arthritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8891",
                    "name": "Gaucher Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M6638",
                    "name": "Crohn Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "M4085",
                    "name": "Anemia, Sickle Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M4070",
                    "name": "Anemia",
                    "asFound": "Anemia",
                    "relevance": "HIGH"
                },
                {
                    "id": "M17917",
                    "name": "Inflammatory Bowel Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11639",
                    "name": "Metabolic Diseases",
                    "asFound": "Metabolic Disorders",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M16680",
                    "name": "Thrombocytopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M12945",
                    "name": "Osteopetrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M2285",
                    "name": "Primary Immunodeficiency Diseases",
                    "asFound": "Primary Immunodeficiency",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10199",
                    "name": "Immunologic Deficiency Syndromes",
                    "relevance": "LOW"
                },
                {
                    "id": "M12041",
                    "name": "Mucopolysaccharidoses",
                    "relevance": "LOW"
                },
                {
                    "id": "M11059",
                    "name": "Mucopolysaccharidosis I",
                    "relevance": "LOW"
                },
                {
                    "id": "M3677",
                    "name": "Adrenoleukodystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M16557",
                    "name": "Thalassemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M19408",
                    "name": "beta-Thalassemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M26695",
                    "name": "Lymphohistiocytosis, Hemophagocytic",
                    "relevance": "LOW"
                },
                {
                    "id": "M3620",
                    "name": "Tissue Adhesions",
                    "relevance": "LOW"
                },
                {
                    "id": "M4479",
                    "name": "Arthritis, Juvenile",
                    "asFound": "Juvenile Idiopathic Arthritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M18927",
                    "name": "Mucopolysaccharidosis II",
                    "relevance": "LOW"
                },
                {
                    "id": "M2241",
                    "name": "Bone Marrow Failure Disorders",
                    "asFound": "Bone Marrow Failure Syndromes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13118",
                    "name": "Pancytopenia",
                    "asFound": "Bone Marrow Failure",
                    "relevance": "HIGH"
                },
                {
                    "id": "M28591",
                    "name": "Leukoencephalopathies",
                    "relevance": "LOW"
                },
                {
                    "id": "M9208",
                    "name": "Granulomatous Disease, Chronic",
                    "relevance": "LOW"
                },
                {
                    "id": "M10968",
                    "name": "Leukodystrophy, Globoid Cell",
                    "relevance": "LOW"
                },
                {
                    "id": "M25409",
                    "name": "Mannosidase Deficiency Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M11352",
                    "name": "alpha-Mannosidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "M27210",
                    "name": "Hyper-IgM Immunodeficiency Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M2242",
                    "name": "Congenital Bone Marrow Failure Syndromes",
                    "asFound": "Congenital Bone Marrow Failure Syndromes",
                    "relevance": "HIGH"
                },
                {
                    "id": "M23456",
                    "name": "Anemia, Diamond-Blackfan",
                    "relevance": "LOW"
                },
                {
                    "id": "M10969",
                    "name": "Leukodystrophy, Metachromatic",
                    "relevance": "LOW"
                },
                {
                    "id": "M17662",
                    "name": "Wiskott-Aldrich Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M18908",
                    "name": "Severe Combined Immunodeficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "M21754",
                    "name": "Dyskeratosis Congenita",
                    "relevance": "LOW"
                },
                {
                    "id": "M28567",
                    "name": "Autoimmune Lymphoproliferative Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "M10621",
                    "name": "Joint Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M15045",
                    "name": "Rheumatic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6323",
                    "name": "Collagen Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6464",
                    "name": "Connective Tissue Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4629",
                    "name": "Autoimmune Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "M5134",
                    "name": "Bone Marrow Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M3170",
                    "name": "Cytopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "M10276",
                    "name": "Infant, Newborn, Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "T2449",
                    "name": "Gaucher Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T1303",
                    "name": "Chronic Graft Versus Host Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T4325",
                    "name": "Osteopetrosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T3901",
                    "name": "Mucopolysaccharidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T3902",
                    "name": "Mucopolysaccharidosis Type I",
                    "relevance": "LOW"
                },
                {
                    "id": "T218",
                    "name": "Adrenomyeloneuropathy",
                    "relevance": "LOW"
                },
                {
                    "id": "T5954",
                    "name": "X-linked Adrenoleukodystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "T5622",
                    "name": "Thalassemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T737",
                    "name": "Beta-thalassemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T5229",
                    "name": "Sickle Cell Anemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T5564",
                    "name": "Systemic Onset Juvenile Idiopathic Arthritis",
                    "asFound": "Systemic Juvenile Idiopathic Arthritis",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3903",
                    "name": "Mucopolysaccharidosis Type II",
                    "relevance": "LOW"
                },
                {
                    "id": "T3395",
                    "name": "Leukodystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "T1304",
                    "name": "Chronic Granulomatous Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T3270",
                    "name": "Krabbe Disease",
                    "relevance": "LOW"
                },
                {
                    "id": "T3394",
                    "name": "Leukocyte Adhesion Deficiency Type 1",
                    "relevance": "LOW"
                },
                {
                    "id": "T299",
                    "name": "Alpha-mannosidosis",
                    "relevance": "LOW"
                },
                {
                    "id": "T2853",
                    "name": "Hurler Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T1837",
                    "name": "Diamond-Blackfan Anemia",
                    "relevance": "LOW"
                },
                {
                    "id": "T3728",
                    "name": "Metachromatic Leukodystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "T5939",
                    "name": "Wiskott Aldrich Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T5187",
                    "name": "Severe Combined Immunodeficiency",
                    "relevance": "LOW"
                },
                {
                    "id": "T2745",
                    "name": "Hereditary Diffuse Leukoencephalopathy With Spheroids",
                    "relevance": "LOW"
                },
                {
                    "id": "T1459",
                    "name": "Congenital Amegakaryocytic Thrombocytopenia",
                    "relevance": "LOW"
                },
                {
                    "id": "T1976",
                    "name": "Dyskeratosis Congenita",
                    "relevance": "LOW"
                },
                {
                    "id": "T560",
                    "name": "Autoimmune Lymphoproliferative Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T4239",
                    "name": "Omenn Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T676",
                    "name": "Bare Lymphocyte Syndrome",
                    "relevance": "LOW"
                },
                {
                    "id": "T677",
                    "name": "Bare Lymphocyte Syndrome 2",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "BC18",
                    "name": "Nutritional and Metabolic Diseases"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "BC17",
                    "name": "Skin and Connective Tissue Diseases"
                },
                {
                    "abbrev": "BC19",
                    "name": "Gland and Hormone Related Diseases"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "C000024352",
                    "term": "Fludarabine"
                },
                {
                    "id": "D000008558",
                    "term": "Melphalan"
                },
                {
                    "id": "D000074323",
                    "term": "Alemtuzumab"
                },
                {
                    "id": "D000013852",
                    "term": "Thiotepa"
                },
                {
                    "id": "D000006918",
                    "term": "Hydroxyurea"
                }
            ],
            "ancestors": [
                {
                    "id": "D000000970",
                    "term": "Antineoplastic Agents"
                },
                {
                    "id": "D000045504",
                    "term": "Molecular Mechanisms of Pharmacological Action"
                },
                {
                    "id": "D000007166",
                    "term": "Immunosuppressive Agents"
                },
                {
                    "id": "D000007155",
                    "term": "Immunologic Factors"
                },
                {
                    "id": "D000045505",
                    "term": "Physiological Effects of Drugs"
                },
                {
                    "id": "D000018906",
                    "term": "Antineoplastic Agents, Alkylating"
                },
                {
                    "id": "D000000477",
                    "term": "Alkylating Agents"
                },
                {
                    "id": "D000019653",
                    "term": "Myeloablative Agonists"
                },
                {
                    "id": "D000074322",
                    "term": "Antineoplastic Agents, Immunological"
                },
                {
                    "id": "D000000986",
                    "term": "Antisickling Agents"
                },
                {
                    "id": "D000004791",
                    "term": "Enzyme Inhibitors"
                },
                {
                    "id": "D000019384",
                    "term": "Nucleic Acid Synthesis Inhibitors"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M9969",
                    "name": "Hydroxyurea",
                    "asFound": "Vitamin C",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11541",
                    "name": "Melphalan",
                    "asFound": "Controlled Study",
                    "relevance": "HIGH"
                },
                {
                    "id": "M283230",
                    "name": "Fludarabine",
                    "asFound": "Rate",
                    "relevance": "HIGH"
                },
                {
                    "id": "M225513",
                    "name": "Fludarabine phosphate",
                    "relevance": "LOW"
                },
                {
                    "id": "M16615",
                    "name": "Thiotepa",
                    "asFound": "Tear",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1347",
                    "name": "Alemtuzumab",
                    "asFound": "Transcranial Direct Current Stimulation",
                    "relevance": "HIGH"
                },
                {
                    "id": "M10212",
                    "name": "Immunosuppressive Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M10201",
                    "name": "Immunologic Factors",
                    "relevance": "LOW"
                },
                {
                    "id": "M20942",
                    "name": "Antineoplastic Agents, Alkylating",
                    "relevance": "LOW"
                },
                {
                    "id": "M3820",
                    "name": "Alkylating Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M1346",
                    "name": "Antineoplastic Agents, Immunological",
                    "relevance": "LOW"
                },
                {
                    "id": "M7951",
                    "name": "Enzyme Inhibitors",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "ANeo",
                    "name": "Antineoplastic Agents"
                },
                {
                    "abbrev": "AnSickAg",
                    "name": "Antisickling Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                }
            ]
        }
    },
    "hasResults": false
}